Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FUJIFILM Biotechnologies Transitions Leadership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

FUJIFILM Biotechnologies Transitions Leadership

Maja Pedersen has been appointed President to drive next phase of operational growth.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Biotechnologies announced a planned leadership transition. Maja Pedersen has been appointed President, in addition to her role as Chief Operating Officer, effective immediately. The appointment is part of a planned leadership succession with Lars Petersen transitioning from his role as President and CEO, effective immediately to Strategic Advisor, through September 30, 2026. 

Over the past several years, Petersen has led FUJIFILM Biotechnologies, under the Partners for Life strategy, building the kojoX*1 global manufacturing network, expanding the company’s international footprint and strengthening its position as a global CDMO.

The company aims to further strengthen its focus on operational excellence, quality, and customer delivery leveraging its established global kojoX manufacturing platform.

Pedersen was appointed to Chief Operating Officer in 2025, and in that role, she is responsible for site operations, supply chain, quality, process development and global manufacturing science and technology (MSAT). Pedersen returned to FUJIFILM Biotechnologies in 2023 to serve as Chief Quality Officer. Prior to that, she was Global Head of External Manufacturing at Biogen, overseeing the entire CDMO network. She has over 20 years of leadership experience in life sciences and biopharma, holding senior leadership positions in quality assurance and control, regulatory affairs and external manufacturing. 

Toshihisa Iida, Chairman of FUJIFILM Biotechnologies said: “We are grateful to Lars’ contributions to the organization and his vision, which will come to life under Maja’s leadership. Maja has already played a pivotal role in building the operational strength of FUJIFILM Biotechnologies. Her deep operational expertise, strong quality leadership and commitment to our people and customers make her exceptionally well positioned to lead the company’s next phase while continuing the strategy that has been successfully established.”  

Maja Pedersen said: “Our strategy remains unchanged. Partners for Life continues to guide everything we do. My focus will be on building upon the strong foundation already in place, delivering consistently for our customers, strengthening quality and operational excellence and continuing to grow our business together with our exceptional people.” 

Iida will continue in his role as Chairman of FUJIFILM Biotechnologies, providing strategic oversight and ensuring alignment with Fujifilm’s global strategic direction to drive the business forward. 

More FUJIFILM news: BriaCell Taps FUJIFILM for Bria-IMT Manufacturing

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics